Exposure of Taxi Drivers to Ultrafine Particles and Black Carbon Within Their Vehicles
NCT ID: NCT03839537
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2019-02-01
2020-06-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Example: The purpose of this study is to determine whether prednisone, methotrexate, and cyclophosphamide are effective in the treatment of rapidly progressive hearing loss in both ears due to autoimmune inner ear disease (AIED). This project is part of a research field on the role, not yet fully understood, of atmospheric pollution, especially from road traffic, on respiratory health and allergies, particularly on the development / onset of symptoms and functional disturbances. The ultrafine fraction of particles (UFPs - particles smaller than 100 nm in diameter) is of recent interest because of their ability to induce inflammatory effects, oxidative stress and may contribute to the exacerbation of asthma symptoms in susceptible individuals. UFPs, with their high number concentration and surface area and their small diameter are able not only to convey other contaminants, but also to contribute to a high deposition efficiency, into the alveoli in the lungs. Recently it appeared relevant to be interested in black carbon (BC), components of PM2.5 (particulate matter with a diameter less than 2.5 micrometers), suspected of being responsible for their toxicity. Current epidemiological knowledge of the effects of UFPs and BC are few as compared to those on fine particles. Some professionals, such as police, drivers (taxis, truckers ...), delivery men, postal workers, workers on roads and highways, etc. are heavily exposed, during their working hours, to air pollution due to road traffic. These occupational groups appear to be at greater risk for developing respiratory, cardiovascular and neurological diseases than the general population. Occupational exposure to diesel exhaust has been associated with an increased risk of lung cancer mortality and chronic obstructive pulmonary disease. Occupational exposure to UFPs and BC has rarely been measured due to a lack of suitable devices. Therefore, this project's originality consists in measuring UFPs and BC by using portable devices developed in the recent years. The use of these devices, linking their recordings with ventilatory measures and repeating them, offers the rare opportunity to study the short-term respiratory health impact of this occupational exposure, which has never been described in the literature. Our research aims to: 1/ quantify the occupational exposure of taxi drivers to UFP, BC, oxides of carbon (CO, CO2) and to nitrogen dioxide (NO2), 2/ identify spatio-temporal variability and patterns of exposure related to occupational tasks, 3/ study the impact of this occupational exposure to UFP and BC on ventilation performances and respiratory symptoms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Differential Pattern of Deposition of Nano Particles in the Airways of Exposed Workers
NCT01599845
Ultrafine Particles and Fetal Contamination
NCT04068389
Effect of Commute Traffic on Vascular Function
NCT05454930
Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults
NCT03232086
Commuter Air Pollution Intervention Study
NCT02277002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure measurement
* 2 measurements per subject (in warm season and in cold season)
* Devices placed inside taxi vehicles on the passenger seat in a sampling bag
Spirometry test
* 2 measurements per subject - before and after the work shift - in warm and cold seasons
* Subject will inhale and exhale in the device
Exhaled carbon monoxide test
* 2 measurements per subject - before and after the work shift - in warm and cold seasons
* Subject will exhale in the device
Skin allergy test
\- Performed by a physician during the inclusion clinical examination
Spirometry test
\- Performed by a physician during the inclusion clinical examination
Fractional Exhaled Nitric Oxide Testing
\- Performed by a physician during the inclusion clinical examination
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Full time licensed taxi driver
* Subjects with more than 6 months of job tenure (as a taxi driver)
* Subjects affiliated to a social security scheme
* Subjects must have signed an informed consent and are willing to participate in the study
Exclusion Criteria
* Subjects with less than 6 months of job tenure (as a taxi driver)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Paris 5 - Rene Descartes
OTHER
Centre national de la recherche scientifique - Lebanon (CNRS-L)
UNKNOWN
French Environment and Energy Management Agency
UNKNOWN
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynda BENSEFA-COLAS, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Paris Descartes University
Paris, Paris, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hachem M, Saleh N, Bensefa-Colas L, Momas I. Determinants of ultrafine particles, black carbon, nitrogen dioxide, and carbon monoxide concentrations inside vehicles in the Paris area: PUF-TAXI study. Indoor Air. 2021 May;31(3):848-859. doi: 10.1111/ina.12779. Epub 2020 Dec 22.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A00811-54
Identifier Type: OTHER
Identifier Source: secondary_id
K180303J
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.